Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

47.34 +0.48 (+1.02%)
Official Closing Price Updated: 4:10 PM EDT, Jul 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,866,160
Open 46.88
Bid (Size) 47.25 (6)
Ask (Size) 47.75 (5)
Prev. Close 46.86
Today's Range 46.88 - 47.97
52wk Range 39.92 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.24%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?
BofA cuts Bristol Myers' 2025 EPS and sales estimates slightly and flags medium-term pressure from generics, while maintaining a Neutral rating. 
Via Benzinga
1 Safe-and-Steady Stock with Exciting Potential and 2 to Brush Off
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory

Performance

YTD
-16.6%
-16.6%
1 Month
-4.8%
-4.8%
3 Month
-7.8%
-7.8%
6 Month
-14.5%
-14.5%
1 Year
+17.9%
+17.9%

More News

Read More
Why Bristol-Myers Squibb (BMY) Shares Are Sliding Today
Via StockStory
Topics ETFs Intellectual Property Stocks
Price Over Earnings Overview: Bristol-Myers Squibb
Via Benzinga
Top S&P500 movers in Friday's session
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
Why Is Nano-Cap MiNK Therapeutics Stock Gaining Over 400% On Friday?
Via Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
Via Chartmill
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade
2 Top Stocks Down 16% and 17% This Year to Buy and Hold
Via The Motley Fool
Topics Intellectual Property
Why Is AbbVie Stock Trading Higher On Thursday?
Via Benzinga
What Analysts Are Saying About Bristol-Myers Squibb Stock
Via Benzinga
Warren Buffett's Quiet Dividend Play: 9 High-Yield Stocks Held By A Berkshire Subsidiary
Via Benzinga
Branded Pharmaceuticals Stocks Q1 Recap: Benchmarking Merck (NYSE:MRK)
Via StockStory
Topics Artificial Intelligence Intellectual Property
Warren Buffett Owns 9 Ultra-High-Yield Dividend Stocks. Here's the Best of the Bunch.
Via The Motley Fool
Topics ETFs Regulatory Compliance
AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment
Via Benzinga
Is Pfizer Stock a Yield Trap?
Via The Motley Fool
Topics Intellectual Property
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Large-Cap Stocks Skating on Thin Ice
Via StockStory
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
Via Benzinga
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - A High-Yield Dividend Stock Worth Considering
Via Chartmill
FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers
Via Benzinga
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels
From Bristol Myers Squibb
Via Business Wire
Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes
Via Investor's Business Daily
Bristol Myers Faces Scrutiny For Allegedly Rigging Market On $2B Cancer Drug
Via Benzinga
Topics Fraud Lawsuit

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 47.34
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 07/14/25 04:10 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 105.19B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 105B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.